SCHEMBL29385649

SCHEMBL29385649

CC(C)c1cc2c(c(O)c1O)C13CCCC(C)(C)C1C(OC3=O)C2N

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FDPS P14324 14/20 0.64
▸ PTGES O14684 2/20 0.64
▸ PNLIP P16233 2/20 0.64
▸ MEN1 O00255 2/20 0.64
▸ KMT2A Q03164 2/20 0.64
▸ GGPS1 O95749 7/20 0.46
▸ BCL9 O00512 3/20 0.41
▸ CTNNB1 P35222 3/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ HPGD P15428 2/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ ALOX12 P18054 1/20 0.41
▸ GSTO1 P78417 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ USP2 O75604 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Rosmanol SCHEMBL459610 0.88 FDPS (0.65) FDPSPTGESPNLIPMEN1KMT2A
Rosmanol SCHEMBL13062163 0.88 FDPS (0.65) FDPSPTGESPNLIPMEN1KMT2A
Epirosmanol SCHEMBL29426648 0.88 FDPS (0.65) FDPSPTGESPNLIPMEN1KMT2A
Epirosmanol SCHEMBL3272202 0.88 FDPS (0.65) FDPSPTGESPNLIPMEN1KMT2A
Rosmanol SCHEMBL28962181 0.88 FDPS (0.65) FDPSPTGESPNLIPMEN1KMT2A
SCHEMBL31238108 0.85 FDPS (0.61) FDPSPTGESPNLIPMEN1KMT2A
Isorosmanol SCHEMBL13294492 0.81 FDPS (0.65) FDPSPTGESPNLIPMEN1KMT2A
Epiisorosmanol SCHEMBL29511557 0.81 FDPS (0.65) FDPSPTGESPNLIPMEN1KMT2A
Isorosmanol SCHEMBL12574307 0.81 FDPS (0.65) FDPSPTGESPNLIPMEN1KMT2A
Isorosmanol SCHEMBL14599481 0.81 FDPS (0.65) FDPSPTGESPNLIPMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240074481-A1 CAPSULE-CONTAINING POUCHED PRODUCT FOR ORAL USE REYNOLDS TOBACCO CO R (US) 2024-03-07 — — US claimed
US-11344057-B2 Capsule-containing pouched product for oral use R.J. REYNOLDS TOBACCO COMPANY (US) 2022-05-31 — — US claimed
US-20220030928-A1 CAPSULE-CONTAINING POUCHED PRODUCT FOR ORAL USE REYNOLDS TOBACCO CO R (US) 2022-02-03 — — US claimed
EP-4442128-A1 SMOKELESS TOBACCO POUCH R. J. Reynolds Tobacco Company (US) 2024-10-09 — — EP disclosed
EP-4410290-A2 SMOKELESS TOBACCO COMPOSITION INCORPORATING A BOTANICAL MATERIAL R.J. Reynolds Tobacco Company (US) 2024-08-07 — — EP disclosed
EP-3226700-B1 SMOKELESS TOBACCO POUCH REYNOLDS TOBACCO CO R (US) 2024-07-10 — — EP disclosed
EP-3043661-B1 SMOKELESS TOBACCO COMPOSITION INCORPORATING A BOTANICAL MATERIAL REYNOLDS TOBACCO CO R (US) 2024-05-29 — — EP disclosed
US-20240074481-A1 CAPSULE-CONTAINING POUCHED PRODUCT FOR ORAL USE REYNOLDS TOBACCO CO R (US) 2024-03-07 — — US disclosed
US-11832640-B2 Capsule-containing pouched product for oral use R.J. REYNOLDS TOBACCO COMPANY (US) 2023-12-05 — — US disclosed
WO-2023180590-A1 COMPOSITION FOR PRODUCING COSMETIC PRODUCTS MARIN GARCIA MARIA GLORIA (ES) 2023-09-28 — — WO disclosed
WO-2023101420-A1 COMPOSITION FOR PREVENTION OR TREATMENT OF OBESITY, FATTY LIVER, OR STEATOHEPATITIS COMPRISING MOMORDICA CHARANTIA EXTRACT OR HYDROFERULIC ACID DERIVED FROM MOMORDICA CHARANTIA AS ACTIVE INGREDIENT 동아대학교 산학협력단 2023-06-08 — — WO disclosed
US-11503853-B2 Smokeless tobacco composition incorporating a botanical material R.J. REYNOLDS TOBACCO COMPANY (US) 2022-11-22 — — US disclosed
US-20220279833-A1 SMOKELESS TOBACCO COMPOSITION INCORPORATING A BOTANICAL MATERIAL REYNOLDS TOBACCO CO R (US) 2022-09-08 — — US disclosed
US-20220264931-A1 CAPSULE-CONTAINING POUCHED PRODUCT FOR ORAL USE REYNOLDS TOBACCO CO R (US) 2022-08-25 — — US disclosed
US-11344057-B2 Capsule-containing pouched product for oral use R.J. REYNOLDS TOBACCO COMPANY (US) 2022-05-31 — — US disclosed
US-20220030928-A1 CAPSULE-CONTAINING POUCHED PRODUCT FOR ORAL USE REYNOLDS TOBACCO CO R (US) 2022-02-03 — — US disclosed
Send feedback